15.7101.63% ( -0.260 )
Delay Closed: Nov 17, 16:08:15Valuation
Current ValuationThe current P/E ratio is 9.74, within the reasonable range, cheaper than 62.45% of the time in the past 1 years, and the industry ranks 11/53, the industry Median 6.96.
9.74xP/E
HK$15.71Stock price
HK$1.61Earnings per share
9.74xP/E
Stock priceHK$15.71Earnings per shareHK$1.61
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 10.22x
- Typical range
- 9.41x–12.37x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.96x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.96x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
02196HKFOSUN PHARMA | 9.48x | 10.29% | HK$38.81B |
03320HKCHINARES PHARMA | 5.88x | 7.23% | HK$28.11B |
01681HKCONSUN PHARMA | 9.74x | 20.92% | HK$13.17B |
02877HKSHINEWAY PHARM | 6.96x | 13.28% | HK$6.45B |
02186HKLUYE PHARMA | 7.65x | 47.27% | HK$6.13B |
02633HKJACOBSON PHARMA | 5.97x | 1.99% | HK$1.80B |
08049HKJILIN CHANGLONG | 6.34x | -- | HK$1.60B |
02348HKDAWNRAYS PHARMA | 5.10x | -- | HK$1.37B |
02161HKJBM HEALTHCARE | 6.15x | 6.78% | HK$1.24B |
00239HKPAK FAH YEOW | 7.42x | -- | HK$733.91M |
00950HKLEE'S PHARM | 4.99x | -- | HK$597.67M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
